Randall J Lanham - Net Worth and Insider Trading
Randall J Lanham Net Worth
The estimated net worth of Randall J Lanham is at least $33,455 dollars as of 2024-09-20. Randall J Lanham is the General Counsel of Nymox Pharmaceutical Corp and owns about 152,900 shares of Nymox Pharmaceutical Corp (NYMXF) stock worth over $33,455. Details can be seen in Randall J Lanham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randall J Lanham has not made any transactions after 2018-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Randall J Lanham
Randall J Lanham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randall J Lanham owns 1 companies in total, including Nymox Pharmaceutical Corp (NYMXF) .
Click here to see the complete history of Randall J Lanham’s form 4 insider trades.
Insider Ownership Summary of Randall J Lanham
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NYMXF | Nymox Pharmaceutical Corp | 2018-10-28 | director & General Counsel |
Randall J Lanham Latest Holdings Summary
Randall J Lanham currently owns a total of 1 stock. Randall J Lanham owns 152,900 shares of Nymox Pharmaceutical Corp (NYMXF) as of October 28, 2018, with a value of $33,455.
Latest Holdings of Randall J Lanham
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NYMXF | Nymox Pharmaceutical Corp | 2018-10-28 | 152,900 | 0.22 | 33,455 |
Holding Weightings of Randall J Lanham
Randall J Lanham Form 4 Trading Tracker
According to the SEC Form 4 filings, Randall J Lanham has made a total of 0 transactions in Nymox Pharmaceutical Corp (NYMXF) over the past 5 years. The most-recent trade in Nymox Pharmaceutical Corp is the acquisition of 2,900 shares on October 28, 2018, which cost Randall J Lanham around $4,988.
Insider Trading History of Randall J Lanham
- 1
Randall J Lanham Trading Performance
GuruFocus tracks the stock performance after each of Randall J Lanham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randall J Lanham is 26.04%. GuruFocus also compares Randall J Lanham's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randall J Lanham within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Randall J Lanham's insider trading performs compared to the benchmark.
Performance of Randall J Lanham
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.06 | | | | | |
| Relative Return to S&P 500(%) | 6.86 | | | | | |
Randall J Lanham Ownership Network
Randall J Lanham Owned Company Details
What does Nymox Pharmaceutical Corp do?
Who are the key executives at Nymox Pharmaceutical Corp?
Randall J Lanham is the director & General Counsel of Nymox Pharmaceutical Corp. Other key executives at Nymox Pharmaceutical Corp include Chief Financial Officer Erik Danielsen , and director & 10 percent owner & CEO Paul Averback .
Nymox Pharmaceutical Corp (NYMXF) Insider Trades Summary
Over the past 18 months, Randall J Lanham made no insider transaction in Nymox Pharmaceutical Corp (NYMXF). Other recent insider transactions involving Nymox Pharmaceutical Corp (NYMXF) include a net purchase of 120,000 shares made by James George Robinson ,
In summary, during the past 3 months, insiders sold 0 shares of Nymox Pharmaceutical Corp (NYMXF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nymox Pharmaceutical Corp (NYMXF) were sold and 120,000 shares were bought by its insiders, resulting in a net purchase of 120,000 shares.
Nymox Pharmaceutical Corp (NYMXF)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nymox Pharmaceutical Corp Insider Transactions
Randall J Lanham Mailing Address
Above is the net worth, insider trading, and ownership report for Randall J Lanham. Currently GuruFocus does not have mailing address information for Randall J Lanham.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
